Market Size and Overview The congenital adrenal hyperplasia (CAH) therapeutic market is estimated to be valued at USD 392.5 million in 2025 and is expected to reach USD 590.2 million by 2032, growing at a compound annual growth rate (CAGR) of 6.00% from 2025 to 2032. https://articlescad.com/congenital-adrenal-hyperplasia-cah-therapeutic-market-size-growth-and-trends-analysis-522550.html